Variant Summary
- HGVS
- —
- Variant Type(s)
- —
- Evidence Items
- 5
Evidence Level Distribution
Level B: 4Level D: 1
Evidence Items
Showing CIViC evidence rows where gene = AREG and variant = Expression.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| B | Predictive | Supports | Sensitivity/Response | Colorectal Cancer | Panitumumab | 4 |
| D | Predictive | Supports | Resistance | Lung Non-small Cell Carcinoma | Crizotinib | 3 |
| B | Predictive | Supports | Sensitivity/Response | Colorectal Cancer | Cetuximab | 3 |
| B | Predictive | Supports | Resistance | Lung Non-small Cell Carcinoma | Crizotinib | 2 |
| B | Predictive | Supports | Resistance | Head And Neck Squamous Cell Carcinoma | Cetuximab,Docetaxel | 2 |